187 related articles for article (PubMed ID: 31189938)
1. "Dual Disease" TgAD/GSS mice exhibit enhanced Alzheimer's disease pathology and reveal PrP
Qin K; Zhao L; Gregory C; Solanki A; Mastrianni JA
Sci Rep; 2019 Jun; 9(1):8524. PubMed ID: 31189938
[TBL] [Abstract][Full Text] [Related]
2. A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP.
Yang W; Cook J; Rassbach B; Lemus A; DeArmond SJ; Mastrianni JA
J Neurosci; 2009 Aug; 29(32):10072-80. PubMed ID: 19675240
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease.
Cortes CJ; Qin K; Cook J; Solanki A; Mastrianni JA
J Neurosci; 2012 Sep; 32(36):12396-405. PubMed ID: 22956830
[TBL] [Abstract][Full Text] [Related]
4. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
5. The pathogenesis of soluble PrP fragments containing Aβ binding sites.
Li B
Virus Res; 2016 Jan; 211():194-8. PubMed ID: 26528810
[TBL] [Abstract][Full Text] [Related]
6. IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease.
Gu H; Kirchhein Y; Zhu T; Zhao G; Peng H; Du E; Liu J; Mastrianni JA; Farlow MR; Dodel R; Du Y
Mol Neurobiol; 2019 Apr; 56(4):2353-2361. PubMed ID: 30027340
[TBL] [Abstract][Full Text] [Related]
7. Anle138b prevents PrP plaque accumulation in Tg(PrP-A116V) mice but does not mitigate clinical disease.
Qin K; Zhao L; Solanki A; Busch C; Mastrianni J
J Gen Virol; 2019 Jun; 100(6):1027-1037. PubMed ID: 31045489
[TBL] [Abstract][Full Text] [Related]
8. Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.
Furukawa F; Sanjo N; Kobayashi A; Hamaguchi T; Yamada M; Kitamoto T; Mizusawa H; Yokota T
Prion; 2018; 12(5-6):315-319. PubMed ID: 30394185
[TBL] [Abstract][Full Text] [Related]
9. An autopsy report of three kindred in a Gerstmann-Sträussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid.
Ishizawa K; Mitsufuji T; Shioda K; Kobayashi A; Komori T; Nakazato Y; Kitamoto T; Araki N; Yamamoto T; Sasaki A
Brain Behav; 2018 Oct; 8(10):e01117. PubMed ID: 30240140
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia.
Ishizawa K; Komori T; Shimazu T; Yamamoto T; Kitamoto T; Shimazu K; Hirose T
Acta Neuropathol; 2002 Oct; 104(4):342-50. PubMed ID: 12200619
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous generation of anchorless prions in transgenic mice.
Stöhr J; Watts JC; Legname G; Oehler A; Lemus A; Nguyen HO; Sussman J; Wille H; DeArmond SJ; Prusiner SB; Giles K
Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21223-8. PubMed ID: 22160704
[TBL] [Abstract][Full Text] [Related]
12. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
Carlson GA; Prusiner SB
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
[TBL] [Abstract][Full Text] [Related]
13. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
14. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
Smith LM; Kostylev MA; Lee S; Strittmatter SM
J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106
[TBL] [Abstract][Full Text] [Related]
15. Memory impairment in transgenic Alzheimer mice requires cellular prion protein.
Gimbel DA; Nygaard HB; Coffey EE; Gunther EC; Laurén J; Gimbel ZA; Strittmatter SM
J Neurosci; 2010 May; 30(18):6367-74. PubMed ID: 20445063
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Prion Protein Aggregates in Nine Gerstmann-Sträussler-Scheinker Syndrome Subjects with Mutation P102L: A Micromorphological Study and Comparison with Literature Data.
Jankovska N; Matej R; Olejar T
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948096
[TBL] [Abstract][Full Text] [Related]
18. Colocalization of prion protein and beta protein in the same amyloid plaques in patients with Gerstmann-Sträussler syndrome.
Miyazono M; Kitamoto T; Iwaki T; Tateishi J
Acta Neuropathol; 1992; 83(4):333-9. PubMed ID: 1349451
[TBL] [Abstract][Full Text] [Related]
19. Prion protein (PrPc) promotes beta-amyloid plaque formation.
Schwarze-Eicker K; Keyvani K; Görtz N; Westaway D; Sachser N; Paulus W
Neurobiol Aging; 2005; 26(8):1177-82. PubMed ID: 15917101
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain.
Takahashi RH; Tobiume M; Sato Y; Sata T; Gouras GK; Takahashi H
Neuropathology; 2011 Jun; 31(3):208-14. PubMed ID: 21062360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
